Compare · ASLE vs ZBH
ASLE vs ZBH
Side-by-side comparison of AerSale Corporation (ASLE) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- ASLE operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $17.34B, about 57.9x ASLE ($299.6M).
- Over the past year, ASLE is up 5.0% and ZBH is down 5.4% - ASLE leads by 10.4 points.
- ZBH has been more active in the news (15 items in the past 4 weeks vs 8 for ASLE).
- ZBH has more recent analyst coverage (25 ratings vs 5 for ASLE).
- Company
- AerSale Corporation
- Zimmer Biomet Holdings Inc.
- Price
- $6.23-1.74%
- $89.75+0.12%
- Market cap
- $299.6M
- $17.34B
- 1M return
- -4.30%
- +12.72%
- 1Y return
- +4.97%
- -5.40%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 8
- 15
- Recent ratings
- 5
- 25
AerSale Corporation
AerSale Corporation provides aftermarket commercial aircraft, engines, and its parts to passenger and cargo airlines, leasing companies, original equipment manufacturers, and government and defense contractors, as well as maintenance, repair, and overhaul (MRO) service providers worldwide. It operates in two segments, Asset Management Solutions and Technical Operations (TechOps). The Asset Management Solutions segment engages in the sale and lease of aircraft, engines, and airframes, as well as disassembly of these assets for component parts. The TechOps segment provides internal and third-party aviation services, including internally developed engineered solutions, heavy aircraft maintenance and modification, and component MRO, as well as storage and disassembly services. This segment also provides aircraft modifications, cargo/tanker conversions of aircraft, and aircraft storage; and MRO services for landing gear, thrust reversers, hydraulic systems, and other aircraft components. The company was founded in 2008 and is headquartered in Coral Gables, Florida.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest ASLE
- Director Nichols Robert B. was granted 19,623 shares (SEC Form 4)
- Director Mullins Thomas Wiese was granted 19,623 shares, increasing direct ownership by 73% to 46,424 units (SEC Form 4)
- Director Mitchell Thomas Duncan was granted 19,623 shares, increasing direct ownership by 81% to 43,880 units (SEC Form 4)
- Director Levy Andrew C was granted 19,623 shares, increasing direct ownership by 32% to 80,528 units (SEC Form 4)
- Director Fedder Judith Ann was granted 19,623 shares, increasing direct ownership by 32% to 81,798 units (SEC Form 4)
- Director Dibattiste Carol was granted 19,623 shares, increasing direct ownership by 81% to 43,880 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by AerSale Corporation
- AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
- SEC Form 10-Q filed by AerSale Corporation
- AerSale Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest ZBH
- SEC Form 4 filed by Officer Noor Jehanzeb
- Group President, Asia Pacific Yi Sang sold $413,216 worth of shares (5,000 units at $82.64), decreasing direct ownership by 16% to 27,251 units (SEC Form 4)
- Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Bernard Betsy J
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Shapiro Louis
- SEC Form 4 filed by Director Kurdikar Devdatt